Back to Top
Adakitug Biosimilar - Research Grade
$710.00 - $6,900.00
Adakitug Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
CXCL8
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P10145
Shipping Conditions
Blue ice
Background
CXCL8 (interleukin-8) is a chemokine that recruits and activates neutrophils and is a central mediator in inflammation and tumour microenvironment research. This anti-human CXCL8 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of adakitug, provided strictly for research use only. Built to rigorous in vivo standards and low in endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a consistent neutralizing control and active reagent in chemokine assays, neutrophil chemotaxis studies, in vitro functional screening, and in vivo inflammation models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review














